Low muscle mass, density linked to shorter survival in DLBCL

Low muscle mass, density linked to shorter survival in DLBCL

(HealthDay)—For patients with diffuse large B-cell lymphoma (DLBCL), the combination of low muscle mass (LMM) and low muscle density (LMD) is an independent prognostic factor for survival, according to a study published in the July issue of Leukemia & Lymphoma.

Hánah N. Rier, M.D., from Albert Schweitzer Hospital in Dordrecht, Netherlands, and colleagues examined the association of LMM and LMD with survival in 164 patients with DLBCL. Computed tomography-based measurement of was performed before chemoimmunotherapy. Z-scores adjusted for gender, age, and body mass index were derived from a healthy reference population; a Z-score less than −1 was used to define LMM or LMD.

The researchers found that LMM and LMD were associated with overall survival (OS) and (PFS). In 13 percent of patients, there was coexistence of both LMM and LMD, which was significantly associated with shorter OS and PFS (multivariable hazard ratios, 2.42 and 2.16, respectively). These did not complete the planned treatment more often (multivariable odds ratio, 2.84).

"The presence of LMM and LMD was not related to preexisting comorbidities or unfavorable characteristics, indicating that the combination of LMM and LMD is a lymphoma-independent risk factor for shorter survival, possibly because it more often results in premature termination of chemotherapy," the authors write.


Explore further

Low muscle mass, density linked to shorter survival in lymphoma

More information: Abstract/Full Text

Copyright © 2020 HealthDay. All rights reserved.

Citation: Low muscle mass, density linked to shorter survival in DLBCL (2020, July 28) retrieved 27 February 2021 from https://medicalxpress.com/news/2020-07-muscle-mass-density-linked-shorter.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
1 shares

Feedback to editors

User comments